- Home
- DRUG vs PDYN Comparison
DRUG vs PDYN Comparison
Compare DRUG & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- PDYN
- Stock Information
- Founded
- DRUG 2019
- PDYN 1983
- Country
- DRUG United States
- PDYN United States
- Employees
- DRUG N/A
- PDYN N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- PDYN Wholesale Distributors
- Sector
- DRUG Health Care
- PDYN Industrials
- Exchange
- DRUG Nasdaq
- PDYN Nasdaq
- Market Cap
- DRUG 260.6M
- PDYN 257.8M
- IPO Year
- DRUG N/A
- PDYN N/A
- Fundamental
- Price
- DRUG $37.65
- PDYN $7.83
- Analyst Decision
- DRUG Strong Buy
- PDYN
- Analyst Count
- DRUG 4
- PDYN 0
- Target Price
- DRUG $84.33
- PDYN N/A
- AVG Volume (30 Days)
- DRUG 91.2K
- PDYN 7.0M
- Earning Date
- DRUG 12-31-2024
- PDYN 02-26-2025
- Dividend Yield
- DRUG N/A
- PDYN N/A
- EPS Growth
- DRUG N/A
- PDYN N/A
- EPS
- DRUG N/A
- PDYN N/A
- Revenue
- DRUG N/A
- PDYN $7,771,000.00
- Revenue This Year
- DRUG N/A
- PDYN N/A
- Revenue Next Year
- DRUG N/A
- PDYN $583.33
- P/E Ratio
- DRUG N/A
- PDYN N/A
- Revenue Growth
- DRUG N/A
- PDYN N/A
- 52 Week Low
- DRUG $0.93
- PDYN $0.45
- 52 Week High
- DRUG $79.02
- PDYN $14.95
- Technical
- Relative Strength Index (RSI)
- DRUG 55.50
- PDYN 47.53
- Support Level
- DRUG $28.21
- PDYN $7.51
- Resistance Level
- DRUG $38.00
- PDYN $9.23
- Average True Range (ATR)
- DRUG 2.86
- PDYN 1.46
- MACD
- DRUG 0.45
- PDYN -0.29
- Stochastic Oscillator
- DRUG 96.42
- PDYN 9.04
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About PDYN Palladyne AI Corp.
Palladyne AI Corp is a software company focused on autonomy for robotic systems. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in a manner akin to human intelligence. AI and ML software platform empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.